Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
NEU.EXC_IT.structural: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,832 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bipolar disorder | PSYCH000023 | 134.51 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 2 | Reaction time | PSYCH000010 | 131.52 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 3 | Worry | PSYCH000032 | 112.97 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 4 | Adjustment disorder | PSYCH000051 | 104.91 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 5 | Professional qualification | SOCIO000003 | 101.04 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 6 | Educational attainment, none | SOCIO000001 | 95.84 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 7 | Seafood preference | DTSUP000016 | 88.68 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 8 | Medical condition | MISCL000028 | 88.61 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 9 | Neuroticism | PSYCH000034 | 87.05 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 10 | Water consumption | DTSUP000004 | 84.76 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 11 | Social activity, none | SOCIO000018 | 80.97 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 12 | Falling risk | MISCL000040 | 79.07 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 13 | Household size | SOCIO000011 | 79.00 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 14 | Residential stability | SOCIO000014 | 75.01 | Socioeconomic | Neural / glial | 3 | 4 | 7 | 9 | |
| 15 | Fat mass | BCOMP000005 | 73.32 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 16 | Processing speed | PSYCH000008 | 72.83 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 17 | Reproductive timing | BEHAV000011 | 72.17 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 18 | Sleep behaviour | BEHAV000016 | 71.26 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 19 | Food preparation preference | DTSUP000021 | 71.06 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 20 | Dietary change, none | DTSUP000005 | 66.77 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 21 | Negative affect | PSYCH000030 | 65.23 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 22 | Occupational physical activity | BEHAV000006 | 65.11 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 23 | Mood symptoms | PSYCH000029 | 63.67 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 24 | Electronic device use | BEHAV000017 | 61.86 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 25 | Cannabis use | PSYCH000045 | 61.66 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 26 | Memory function | PSYCH000007 | 61.42 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 27 | Abdominal and pelvic pain | GASTR000043 | 61.36 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 28 | Body mass index, BMI | BMORP000002 | 60.90 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 29 | Daytime napping | BEHAV000015 | 59.86 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 30 | Cognitive function | PSYCH000002 | 59.41 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 31 | Intelligence | PSYCH000004 | 57.80 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 32 | Body size, childhood | BMORP000004 | 57.36 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 33 | Flavour preference | DTSUP000022 | 57.34 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 34 | Creativity | PSYCH000003 | 57.25 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 35 | Mood disorder, none | PSYCH000021 | 57.00 | Psychiatric | Neural / glial | — | 2 | 8 | 13 | |
| 36 | Meat preference | DTSUP000015 | 56.77 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 37 | Arm fat percentage | BCOMP000012 | 56.18 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 38 | Educational attainment | SOCIO000002 | 56.16 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 39 | Female genital inflammation | REPRO000008 | 55.35 | Reproductive | Neural / glial | 0 | 2 | 4 | 4 | |
| 40 | Medication, hypnotic or sedative | PSYCH000020 | 54.98 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 41 | Frailty, limited social support | SOCIO000017 | 53.84 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 42 | Drink temperature | DTSUP000003 | 53.78 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 43 | Obesity | METBL000008 | 53.34 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 44 | Viral hepatitis | IMMUN000076 | 53.21 | Immunologic | Neural / glial | 3 | 4 | 10 | 17 | |
| 45 | Commuting transport | SOCIO000004 | 53.14 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 46 | Sphingolipids | LIPID000071 | 52.82 | Lipids | Neural / glial | 0 | 1 | 4 | 7 | |
| 47 | Age at onset of walking | NEURO000023 | 52.31 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 48 | Sun exposure | BEHAV000001 | 52.06 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 49 | Dietary preference | DTSUP000008 | 51.82 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 50 | Sedentary behaviour | BEHAV000008 | 51.32 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 51 | Sexual behaviour | BEHAV000012 | 50.73 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 52 | Waist circumference | BMORP000013 | 50.68 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 53 | Weight | BMORP000015 | 48.31 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 54 | Taste preference | DTSUP000023 | 46.93 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 55 | Fruit preference | DTSUP000012 | 46.70 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 56 | Autoimmune hepatitis | IMMUN000024 | 46.46 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 57 | Severe mental illness | PSYCH000017 | 46.27 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 58 | Social support | SOCIO000022 | 44.68 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 59 | Supplement use, glucosamine | DTSUP000025 | 44.64 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 60 | Coffee preference | DTSUP000002 | 44.58 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 61 | Alcohol use | PSYCH000043 | 43.30 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 62 | Social activity | SOCIO000020 | 43.08 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 63 | CAMK1D levels | PROLV000259 | 43.00 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 64 | PPIE levels | PROLV001607 | 42.53 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 65 | Alcohol consumption | PSYCH000041 | 42.50 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 66 | Central serous chorioretinopathy | OPHTH000035 | 42.30 | Ophthalmic | Hepatocyte | 11 | 2 | 5 | 15 | |
| 67 | Schizophrenia | PSYCH000036 | 41.77 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 68 | Household income | SOCIO000026 | 41.62 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 69 | Trunk fat percentage | BCOMP000018 | 41.14 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 70 | Circadian timing | BEHAV000014 | 40.80 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 71 | Snack and fast-food preference | DTSUP000017 | 40.61 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 72 | Consultant specialty, anaesthetics | MISCL000015 | 40.20 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 73 | Frailty, disability | MISCL000038 | 40.19 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 74 | Movement disorder | NEURO000015 | 39.99 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 75 | Smoking behaviour | PSYCH000046 | 38.48 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 76 | Supplement use, dietary | DTSUP000024 | 38.17 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 77 | Frailty, poorer cognition | PSYCH000001 | 37.99 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 78 | PGLS levels | PROLV001545 | 37.88 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 79 | AGT levels | PROLV000059 | 37.74 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 80 | Leg fat percentage | BCOMP000015 | 37.32 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 81 | Chronic illness or disability | MISCL000004 | 37.25 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 82 | Social relationships | SOCIO000021 | 36.86 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 83 | Parkinson disease | NEURO000022 | 36.78 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 84 | Loneliness | PSYCH000055 | 36.59 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 85 | Vegetable preference | DTSUP000020 | 36.59 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 86 | Cereal preference | DTSUP000010 | 36.31 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 87 | Dietary restriction | DTSUP000009 | 35.88 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 88 | Hip circumference | BMORP000011 | 35.47 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 89 | Dyspnoea | RESPI000028 | 35.15 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 90 | Household composition | SOCIO000010 | 34.70 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 91 | Legume preference | DTSUP000014 | 34.14 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 92 | Transport mode | BEHAV000009 | 33.87 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 93 | Urinary tract infection | IMMUN000074 | 33.82 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 94 | Grain and bakery preference | DTSUP000013 | 33.79 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 95 | CFHR1 levels | PROLV000414 | 33.32 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 96 | Supplement use, mineral or vitamin, none | DTSUP000027 | 33.26 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 97 | Sodium | METAB000050 | 32.62 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 98 | KLK6/PTPRN2 ratio | PRORT001410 | 32.35 | Protein ratios | Neural / glial | 6 | 4 | 10 | 13 | |
| 99 | Multiple system atrophy | NEURO000020 | 32.29 | Neurologic | Neural / glial | 0 | 3 | 6 | 16 | |
| 100 | Insomnia | PSYCH000038 | 32.17 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 101 | FSTL3 levels | PROLV000831 | 31.40 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 102 | Body fat percentage | BCOMP000004 | 31.37 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 103 | Frailty, general | MISCL000039 | 31.31 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 104 | Depression or anxiety | PSYCH000025 | 31.21 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 105 | Physical activity | BEHAV000007 | 31.19 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 106 | Beta-cell function | METBL000036 | 31.04 | Metabolic | Neural / glial | 0 | 1 | 5 | 13 | |
| 107 | Dietary pattern | DTSUP000007 | 30.42 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 108 | Non-cancer illness burden | MISCL000029 | 30.07 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 109 | Pregnancy complication, abortive | REPRO000027 | 29.98 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 110 | Leg mass | BCOMP000017 | 29.66 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 111 | Self-rated health | MISCL000013 | 29.46 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 112 | Mood disorder | PSYCH000028 | 29.40 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 113 | Beverage preference | DTSUP000001 | 29.39 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 114 | Gastrointestinal endoscopy | GASTR000042 | 29.33 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 115 | Supplement use, mineral or vitamin | DTSUP000026 | 29.29 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 116 | Cellulitis and abscess | IMMUN000055 | 29.12 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 117 | Metabolic syndrome | METBL000015 | 29.05 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 118 | CHGB levels | PROLV000427 | 28.90 | Protein levels | Neural / glial | 3 | 2 | 6 | 15 | |
| 119 | APOE levels | PROLV000124 | 28.73 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 120 | Irritable bowel syndrome | GASTR000004 | 28.66 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 121 | Fatty acids, docosahexaenoic acid | LIPID000020 | 28.24 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 122 | Medication, cardiovascular | VASCU000036 | 28.18 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 123 | MOG/PTPRN2 ratio | PRORT001551 | 28.13 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 124 | SPON2 levels | PROLV001937 | 27.83 | Protein levels | Hepatocyte | 44 | 4 | 9 | 17 | |
| 125 | Disability allowance, none | SOCIO000016 | 27.78 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 126 | Occupation | SOCIO000006 | 27.35 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 127 | Social and economic stability | SOCIO000028 | 27.26 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 128 | Medication, GERD | GASTR000014 | 26.68 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 129 | Consultant specialty, gastroenterology | GASTR000007 | 26.65 | Gastrointestinal | Neural / glial | 0 | 5 | 12 | 16 | |
| 130 | Depressive symptoms | PSYCH000026 | 26.44 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 131 | Alcohol preference | PSYCH000042 | 26.36 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 132 | Trauma exposure | PSYCH000054 | 26.11 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 133 | Depression | PSYCH000024 | 25.77 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 134 | DCXR/GSTA1 ratio | PRORT000876 | 25.75 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 135 | MGAT2 levels | PROLV001308 | 25.30 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 136 | Sciatica | NEURO000033 | 25.06 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 137 | Risk-taking behaviour | BEHAV000013 | 25.02 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 138 | Hearing difficulty | AUDIO000012 | 24.75 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 139 | GLRX2 levels | PROLV000897 | 24.49 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 140 | Tinnitus | AUDIO000014 | 24.07 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 141 | Psychiatric care | PSYCH000015 | 23.72 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 142 | Anxiety | PSYCH000022 | 23.26 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 143 | Auditory performance | AUDIO000009 | 22.95 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 144 | Sweets preference | DTSUP000019 | 22.76 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 145 | Narcolepsy | NEURO000036 | 22.55 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 146 | GLB1/GUSB ratio | PRORT001215 | 22.53 | Protein ratios | Hepatocyte | 40 | 2 | 8 | 12 | |
| 147 | Sleep duration | PSYCH000040 | 22.45 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 148 | Wellbeing | PSYCH000056 | 22.30 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 149 | Medication, analgesic | MISCL000034 | 22.27 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 150 | Erectile dysfunction | VASCU000048 | 22.09 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 151 | SFRP2 levels | PROLV001845 | 21.79 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 152 | Vaccination | IMMUN000085 | 21.73 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 153 | Study participation | BEHAV000004 | 21.60 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 154 | Paroxysmal neurological disorder | NEURO000035 | 21.57 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 155 | MAX/TDRKH ratio | PRORT001504 | 21.49 | Protein ratios | Myeloid | 0 | 4 | 11 | 11 | |
| 156 | EHMT2 levels | PROLV000691 | 21.32 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 157 | CRKL/DBNL ratio | PRORT000762 | 21.11 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 158 | Gait abnormality | NEURO000014 | 21.02 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 159 | Dairy preference | DTSUP000011 | 20.99 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 160 | Premature cardiac beat | CARDI000023 | 20.85 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 161 | Dietary change | DTSUP000006 | 20.67 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 162 | Bowel function | GASTR000002 | 20.51 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 163 | Housing tenure | SOCIO000012 | 20.48 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 164 | Functional gastrointestinal disorder | GASTR000003 | 20.33 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 165 | Passive smoking | MISCL000007 | 20.29 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 166 | Gastritis and duodenitis | GASTR000049 | 20.23 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 167 | MLN/TNFRSF12A ratio | PRORT001539 | 20.07 | Protein ratios | Neural / glial | 18 | 1 | 3 | 4 | |
| 168 | ST6GALNAC2 levels | PROLV001954 | 20.07 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 169 | Soft tissue disorder | MSKEL000069 | 20.03 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 170 | Vehicle ownership | SOCIO000015 | 19.98 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 171 | Corrective lens use | OPHTH000032 | 19.97 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 172 | Disability allowance | SOCIO000019 | 19.96 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 173 | Stressful life events | PSYCH000053 | 19.73 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 174 | Ataxia | NEURO000013 | 19.54 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 175 | Major depressive disorder | PSYCH000027 | 19.53 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 176 | Urinary system disorder | NEPHR000005 | 19.40 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 177 | RNASEH2A levels | PROLV001741 | 19.39 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 178 | PALM2 levels | PROLV001490 | 19.04 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 179 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 18.89 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 180 | TIGIT levels | PROLV002034 | 18.82 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 181 | Chest pain | CARDI000052 | 18.81 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 182 | Pain, chronic | MSKEL000034 | 18.75 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 183 | NSFL1C/RILP ratio | PRORT001600 | 18.72 | Protein ratios | Neural / glial | 57 | 6 | 11 | 31 | |
| 184 | Weight-to-muscle ratio | BCOMP000010 | 18.54 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 185 | Oestrogen metabolite | ENDOC000009 | 18.53 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 186 | PRR15 levels | PROLV001641 | 18.50 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 187 | LEPR/NTRK2 ratio | PRORT001448 | 18.40 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 188 | Handedness | BEHAV000003 | 18.27 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 189 | ERBB2/GUSB ratio | PRORT001043 | 18.06 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 190 | Venous insufficiency | VASCU000065 | 17.87 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 191 | ACY1/DCXR ratio | PRORT000019 | 17.80 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 192 | MSRA/PRDX5 ratio | PRORT001562 | 17.69 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 193 | Oesophageal disorder | GASTR000050 | 17.46 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 194 | HLA-DQA2 levels | PROLV000974 | 17.33 | Protein levels | Neural / glial | 5 | 4 | 7 | 9 | |
| 195 | BLVRB/HMBS ratio | PRORT000243 | 17.32 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 196 | Basal metabolic rate | METBL000007 | 17.22 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 197 | PYY levels | PROLV001690 | 16.95 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 198 | Cutaneous abscess | IMMUN000057 | 16.70 | Immunologic | Neural / glial | 0 | 2 | 7 | 15 | |
| 199 | Mental distress | PSYCH000014 | 16.66 | Psychiatric | Muscle / cardiac | 2 | 7 | 11 | 20 | |
| 200 | PTPRN2/RTBDN ratio | PRORT001724 | 16.65 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 201 | CHGA levels | PROLV000426 | 16.38 | Protein levels | Neural / glial | 33 | 2 | 5 | 12 | |
| 202 | Medication use | MISCL000037 | 15.97 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 203 | FXN/METAP1D ratio | PRORT001194 | 15.96 | Protein ratios | Neural / glial | 3 | 3 | 7 | 19 | |
| 204 | ELOA levels | PROLV000701 | 15.90 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 205 | Hearing loss | AUDIO000013 | 15.82 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 206 | CEBPB/PXN ratio | PRORT000592 | 15.78 | Protein ratios | Neural / glial | 0 | 3 | 6 | 17 | |
| 207 | Hearing difficulty, none | AUDIO000005 | 15.61 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 208 | Cortical thickness | NIMAG000010 | 15.39 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 209 | Cough | RESPI000027 | 15.26 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 210 | Prospective memory | PSYCH000009 | 15.14 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 211 | AXIN1/MAVS ratio | PRORT000175 | 15.11 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 212 | Exercise workload | CARDI000024 | 14.91 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 213 | Alcohol use disorder | PSYCH000044 | 14.80 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 214 | Respiratory symptom | RESPI000032 | 14.77 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 215 | Arm mass | BCOMP000014 | 14.76 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 216 | HGF levels | PROLV000965 | 14.72 | Protein levels | Neural / glial | 29 | 4 | 13 | 15 | |
| 217 | FADD/NCK2 ratio | PRORT001106 | 14.70 | Protein ratios | Neural / glial | 6 | 3 | 8 | 14 | |
| 218 | Brain age gap | NIMAG000004 | 14.66 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 219 | PCOLCE levels | PROLV001510 | 14.63 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 220 | Frailty, unhealthy lifestyle | BEHAV000002 | 14.60 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 221 | Suicidal behaviour | PSYCH000037 | 14.53 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 222 | Luteinizing hormone | ENDOC000008 | 14.41 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 223 | Peripheral neuropathy | NEURO000032 | 14.37 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 224 | SMNDC1 levels | PROLV001898 | 14.30 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 225 | Birth weight availability | MISCL000005 | 14.19 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 226 | Intestinal disorder | GASTR000012 | 14.17 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 227 | Pregnancy complication, preterm labour | REPRO000034 | 14.16 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 228 | Pain, joint | MSKEL000036 | 14.14 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 229 | Endocrine gland disorder | ENDOC000003 | 14.12 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 230 | Liver volume | HPBIL000025 | 14.07 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 231 | Digestive system symptoms | GASTR000044 | 14.01 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 232 | Abdominal adiposity | BCOMP000003 | 13.99 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 233 | Hearing loss, sensorineural | AUDIO000008 | 13.89 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 234 | MAP2K6/NT5C3A ratio | PRORT001486 | 13.77 | Protein ratios | Muscle / cardiac | 12 | 6 | 8 | 16 | |
| 235 | MAP4K5/TBCB ratio | PRORT001491 | 13.74 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 236 | Headache | NEURO000009 | 13.69 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 237 | SPOCK2 levels | PROLV001935 | 13.62 | Protein levels | Hepatocyte | 5 | 2 | 6 | 12 | |
| 238 | Gestational age at birth | REPRO000040 | 13.58 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 239 | Pain, none | MSKEL000041 | 13.47 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 240 | Stressful life events, none | PSYCH000050 | 13.32 | Psychiatric | Neural / glial | 7 | 6 | 15 | 10 | |
| 241 | Parental longevity | AGING000003 | 13.31 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 242 | Housing type | SOCIO000013 | 13.23 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 243 | COL15A1 levels | PROLV000483 | 13.20 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 244 | Pre-existing hypertension, pregnancy | VASCU000044 | 13.18 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 245 | Sleep apnoea | RESPI000035 | 13.08 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 246 | Medication use, pain etc, none | MISCL000032 | 12.95 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 247 | Haemoglobin status | HEMAT000009 | 12.85 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 248 | Mental disorder | PSYCH000013 | 12.79 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 249 | EIF4G1/FKBP5 ratio | PRORT001008 | 12.59 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 250 | BACH1/SNX9 ratio | PRORT000199 | 12.55 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 11 | |
| 251 | Weight change | BMORP000016 | 12.52 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 252 | CTSH levels | PROLV000565 | 12.52 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 253 | Medication, anti-malarial | IMMUN000083 | 12.47 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 254 | CIAPIN1/SNX9 ratio | PRORT000617 | 12.45 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 255 | Pain, back | MSKEL000033 | 12.42 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 256 | Administrative status | MISCL000021 | 12.35 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 257 | Sleep disorder | PSYCH000039 | 12.28 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 258 | Surgical history | MISCL000031 | 12.06 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 259 | Citrulline | METAB000020 | 11.95 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 260 | NEFL levels | PROLV001389 | 11.91 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 261 | Liver fat | HPBIL000023 | 11.74 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 262 | NCR3 levels | PROLV001383 | 11.69 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 263 | CNTN3/NCS1 ratio | PRORT000687 | 11.65 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 16 | |
| 264 | Occupational attainment | SOCIO000007 | 11.64 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 265 | COL6A3/SPON2 ratio | PRORT000701 | 11.56 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 266 | Vitiligo | IMMUN000046 | 11.40 | Immunologic | Neural / glial | — | 0 | 3 | 6 | |
| 267 | NPDC1/TAFA5 ratio | PRORT001595 | 11.31 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 268 | NOMO1 levels | PROLV001413 | 11.28 | Protein levels | Hepatocyte | 96 | 3 | 11 | 18 | |
| 269 | Alpha-1-antitrypsin deficiency | RESPI000005 | 11.10 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 270 | Joint injection | MSKEL000048 | 10.92 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 271 | Pregnancy complication, general | REPRO000029 | 10.71 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 272 | Circulatory disorder | VASCU000025 | 10.65 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 273 | UBAC1 levels | PROLV002132 | 10.60 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 274 | DCXR/SCLY ratio | PRORT000878 | 10.60 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 12 | |
| 275 | Spread preference | DTSUP000018 | 10.56 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 276 | Operation, cardiac | CARDI000046 | 10.51 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 277 | Pregnancy termination | BEHAV000010 | 10.47 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 278 | Pain, generic | MSKEL000035 | 10.28 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 279 | NAGA levels | PROLV001371 | 10.25 | Protein levels | Myeloid | 46 | 5 | 9 | 12 | |
| 280 | Epilepsy | NEURO000034 | 10.21 | Neurologic | Myeloid | 0 | 2 | 5 | 19 | |
| 281 | Pain, multi-site | MSKEL000038 | 10.21 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 282 | GKN2 levels | PROLV000892 | 10.18 | Protein levels | Neural / glial | 14 | 0 | 5 | 4 | |
| 283 | Migraine | NEURO000010 | 10.12 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 284 | TPM2 levels | PROLV002095 | 10.06 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 285 | TPI1 levels | PROLV002093 | 9.97 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 286 | CELSR2 levels | PROLV000398 | 9.96 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 287 | CNTN4 levels | PROLV000478 | 9.93 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 288 | EFNA1/PIK3IP1 ratio | PRORT000989 | 9.91 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 289 | GDF15 levels | PROLV000869 | 9.89 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 290 | C1QTNF1 levels | PROLV000224 | 9.86 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 291 | CCL28/PDGFB ratio | PRORT000354 | 9.81 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 6 | 27 | |
| 292 | REN levels | PROLV001723 | 9.79 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 293 | Diabetes, type 2 with complication | METBL000033 | 9.78 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 294 | SCG2 levels | PROLV001784 | 9.78 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 295 | Healthcare cost | SOCIO000025 | 9.77 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 296 | Medication, antimigraine | NEURO000011 | 9.76 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 297 | F8 levels | PROLV000749 | 9.71 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 298 | GPD1 levels | PROLV000921 | 9.65 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 299 | ESR1 levels | PROLV000735 | 9.64 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 300 | ATOX1/TMSB10 ratio | PRORT000153 | 9.54 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 301 | Loose teeth | DENTA000012 | 9.47 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 302 | Potassium | METAB000049 | 9.41 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 303 | Cerebral ischaemia | VASCU000012 | 9.40 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 304 | Dentures | DENTA000006 | 9.35 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 305 | Social trust | SOCIO000023 | 9.33 | Socioeconomic | Stromal / connective | 0 | 5 | 12 | 19 | |
| 306 | PPM1F levels | PROLV001611 | 9.31 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 307 | ARNT levels | PROLV000144 | 9.28 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 308 | Stimulant use disorder | PSYCH000048 | 9.27 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 309 | ARG1 levels | PROLV000134 | 9.19 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 310 | TAX1BP3 levels | PROLV001995 | 9.18 | Protein levels | Myeloid | 0 | 2 | 5 | 6 | |
| 311 | PTPRB levels | PROLV001673 | 9.16 | Protein levels | Vascular | 89 | 3 | 11 | 17 | |
| 312 | Fatty acids, omega-3 | LIPID000024 | 9.07 | Lipids | Hepatocyte | 605 | 2 | 9 | 17 | |
| 313 | CD99 levels | PROLV000363 | 9.07 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 314 | Fracture fixation | MSKEL000047 | 8.98 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 315 | BSG/PCDH1 ratio | PRORT000250 | 8.98 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 316 | Acquired absence of organs | MISCL000027 | 8.89 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 317 | SEMA3G levels | PROLV001808 | 8.84 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 318 | Substance use | PSYCH000049 | 8.71 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 319 | CCL25/PRSS27 ratio | PRORT000353 | 8.69 | Protein ratios | Lymphocyte | 1 | 2 | 9 | 18 | |
| 320 | METAP1D/VASH1 ratio | PRORT001522 | 8.66 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 321 | FGFR4 levels | PROLV000802 | 8.63 | Protein levels | Hepatocyte | 102 | 2 | 8 | 24 | |
| 322 | Hospital admission | MISCL000022 | 8.60 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 323 | L1CAM/SEZ6L ratio | PRORT001417 | 8.55 | Protein ratios | Myeloid | 3 | 1 | 8 | 17 | |
| 324 | Patellar disorder | MSKEL000018 | 8.51 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 325 | CCBL2 levels | PROLV000274 | 8.50 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 326 | FAM174A levels | PROLV000763 | 8.48 | Protein levels | Adipose | 0 | 1 | 9 | 10 | |
| 327 | SCARA5/TGFBI ratio | PRORT001759 | 8.43 | Protein ratios | Hepatocyte | 10 | 3 | 6 | 12 | |
| 328 | STAMBP/WWP2 ratio | PRORT001817 | 8.43 | Protein ratios | Muscle / cardiac | 8 | 4 | 9 | 20 | |
| 329 | Snoring | RESPI000036 | 8.38 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 330 | BLVRB/HBQ1 ratio | PRORT000242 | 8.37 | Protein ratios | Muscle / cardiac | 11 | 3 | 8 | 13 | |
| 331 | Cancer, Oropharynx | MALIG000022 | 8.33 | Malignancy | Neural / glial | 0 | 6 | 13 | 22 | |
| 332 | BCL2 levels | PROLV000185 | 8.31 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 333 | METAP1D/PLXNA4 ratio | PRORT001521 | 8.30 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 334 | CUZD1 levels | PROLV000571 | 8.29 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 335 | Working hours | SOCIO000009 | 8.26 | Socioeconomic | Myeloid | 0 | 2 | 7 | 7 | |
| 336 | Diabetes, type 1 with complication | IMMUN000011 | 8.23 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 337 | Medication, anti-depressant | PSYCH000019 | 8.17 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 338 | HGF/PLAUR ratio | PRORT001285 | 8.14 | Protein ratios | Hepatocyte | 46 | 2 | 13 | 18 | |
| 339 | CRIP2 levels | PROLV000523 | 8.06 | Protein levels | Myeloid | 32 | 5 | 13 | 19 | |
| 340 | Heart rate | CARDI000021 | 8.01 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 341 | CDH2 levels | PROLV000374 | 7.95 | Protein levels | Hepatocyte | 137 | 1 | 11 | 25 | |
| 342 | Pain, neck and shoulder | MSKEL000039 | 7.94 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 343 | Vitreous disorder | OPHTH000047 | 7.90 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 344 | CD84 levels | PROLV000359 | 7.87 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 345 | Employment status | SOCIO000005 | 7.86 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 346 | CHI3L1/HSPG2 ratio | PRORT000610 | 7.86 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 347 | FKBP5/MITD1 ratio | PRORT001158 | 7.83 | Protein ratios | Hepatocyte | 8 | 1 | 8 | 7 | |
| 348 | DECR1/MAP2K6 ratio | PRORT000882 | 7.81 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 349 | PODXL2/SDC1 ratio | PRORT001696 | 7.79 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 350 | Operation, reproductive | REPRO000042 | 7.79 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 351 | Lacrimal disorder | OPHTH000020 | 7.71 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 352 | ZNRF4 levels | PROLV002214 | 7.66 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 353 | Vertigo | AUDIO000021 | 7.64 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 354 | ARSA/GUSB ratio | PRORT000143 | 7.55 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 355 | APOBR levels | PROLV000121 | 7.53 | Protein levels | Myeloid | 25 | 2 | 9 | 17 | |
| 356 | Medication, anti-cancer | MALIG000048 | 7.39 | Malignancy | Epithelial | 9 | 0 | 5 | 9 | |
| 357 | Hypothyroxinemia | ENDOC000022 | 7.33 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 358 | CD99/KITLG ratio | PRORT000534 | 7.29 | Protein ratios | Hepatocyte | 32 | 1 | 8 | 13 | |
| 359 | CD109 levels | PROLV000309 | 7.28 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 360 | Psychiatric disorder | PSYCH000016 | 7.26 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 361 | Shoulder lesion | MSKEL000068 | 7.19 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 362 | Chalazion | OPHTH000017 | 7.19 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 363 | WFDC5 levels | PROLV002190 | 7.17 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 364 | Rotator cuff disorder | MSKEL000066 | 7.11 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 365 | Brain functional connectivity | NIMAG000002 | 7.07 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 366 | Complement system disorder | IMMUN000048 | 7.06 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 367 | CNTNAP2/DPP6 ratio | PRORT000690 | 7.02 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 368 | Cerebellar volume | NIMAG000019 | 7.01 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 369 | Sex-differentiated cardiometabolic traits | MISCL000002 | 6.94 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 370 | Leg impedance | BCOMP000016 | 6.92 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 371 | NAGK levels | PROLV001372 | 6.89 | Protein levels | Muscle / cardiac | 78 | 3 | 13 | 23 | |
| 372 | EHD3 levels | PROLV000690 | 6.88 | Protein levels | Stromal / connective | 14 | 5 | 8 | 17 | |
| 373 | ITIH4 levels | PROLV001119 | 6.81 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 374 | UNC5D levels | PROLV002141 | 6.80 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 375 | PDCD6IP levels | PROLV001519 | 6.79 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 376 | Alanine metabolite | METAB000001 | 6.76 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 377 | CA1/CA2 ratio | PRORT000267 | 6.75 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 378 | LAYN/PTPRN2 ratio | PRORT001433 | 6.74 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 379 | ITGB1BP2/MITD1 ratio | PRORT001385 | 6.74 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 380 | ADAMTSL4 levels | PROLV000037 | 6.69 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 381 | PAPL levels | PROLV001494 | 6.67 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 382 | Sleep-related movement disorder | NEURO000016 | 6.62 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 383 | Neurological disorder | NEURO000008 | 6.59 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 384 | Retirement wellbeing | SOCIO000027 | 6.51 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 385 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 6.51 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 386 | Pain, limb | MSKEL000037 | 6.50 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 387 | Medication, analgesic or antidepressant | MISCL000033 | 6.50 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 388 | CREG1/GUSB ratio | PRORT000751 | 6.45 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 389 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 6.44 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 390 | Muscular dystrophy | MSKEL000028 | 6.37 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 391 | Amyotrophic lateral sclerosis, ALS | NEURO000017 | 6.37 | Neurologic | Myeloid | 13 | 1 | 4 | 7 | |
| 392 | RSPO1/RSPO3 ratio | PRORT001750 | 6.37 | Protein ratios | Myeloid | 5 | 4 | 6 | 14 | |
| 393 | LEP levels | PROLV001199 | 6.36 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 394 | FUT3 levels | PROLV000837 | 6.33 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 395 | Testicular dysfunction | REPRO000016 | 6.33 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 396 | ITPR1 levels | PROLV001122 | 6.32 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 397 | PIK3IP1/RGMB ratio | PRORT001665 | 6.30 | Protein ratios | Neural / glial | 0 | 0 | 8 | 11 | |
| 398 | Occupational respiratory symptoms | RESPI000030 | 6.28 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 399 | BCR/DECR1 ratio | PRORT000223 | 6.24 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 31 | |
| 400 | HRG levels | PROLV000988 | 6.23 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 401 | Goitre | ENDOC000019 | 6.22 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 402 | SELPLG levels | PROLV001806 | 6.20 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 403 | Hearing loss, age-related | AUDIO000006 | 6.15 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 404 | Diabetes, with complication | METBL000035 | 6.15 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 405 | Cerebrovascular disease | VASCU000013 | 6.14 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 406 | AK1/NSFL1C ratio | PRORT000062 | 6.13 | Protein ratios | Hepatocyte | 0 | 2 | 5 | 21 | |
| 407 | Physical activity, none | BEHAV000005 | 6.09 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 408 | CEACAM1/GGT1 ratio | PRORT000586 | 6.08 | Protein ratios | Hepatocyte | 33 | 1 | 4 | 9 | |
| 409 | RND3 levels | PROLV001743 | 6.03 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 410 | FADD/PPP1R2 ratio | PRORT001109 | 6.03 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 411 | Glutathione metabolites | METAB000006 | 6.02 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 412 | LYZL2 levels | PROLV001255 | 5.98 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 413 | FKBP5/MAP4K5 ratio | PRORT001157 | 5.91 | Protein ratios | Hepatocyte | 18 | 1 | 4 | 21 | |
| 414 | Loud music exposure | MISCL000006 | 5.91 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 415 | Anorexia nervosa | PSYCH000011 | 5.90 | Psychiatric | Myeloid | 0 | 1 | 8 | 7 | |
| 416 | CHMP1A levels | PROLV000431 | 5.87 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 417 | Hypertensive heart disease | CARDI000038 | 5.85 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 418 | EFNA4/LAYN ratio | PRORT000990 | 5.84 | Protein ratios | Muscle / cardiac | 3 | 3 | 8 | 13 | |
| 419 | EGFLAM levels | PROLV000686 | 5.74 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 420 | LTBR levels | PROLV001244 | 5.73 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 421 | Lysophosphatidylethanolamines | LIPID000055 | 5.70 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 422 | Hashimoto thyroiditis | IMMUN000028 | 5.69 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 423 | APOF levels | PROLV000125 | 5.68 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 424 | Retinal detachments and defects | OPHTH000039 | 5.68 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 425 | IL1R1 levels | PROLV001060 | 5.67 | Protein levels | Hepatocyte | 77 | 2 | 7 | 15 | |
| 426 | THTPA levels | PROLV002030 | 5.66 | Protein levels | Neural / glial | 0 | 4 | 9 | 37 | |
| 427 | PXN levels | PROLV001688 | 5.65 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 428 | EREG/TIMP3 ratio | PRORT001059 | 5.64 | Protein ratios | Myeloid | 5 | 2 | 13 | 18 | |
| 429 | CSF1/IL10RB ratio | PRORT000777 | 5.59 | Protein ratios | Myeloid | 1 | 1 | 4 | 10 | |
| 430 | Cardiovascular age gap | CARDI000001 | 5.57 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 431 | Insulin levels | METBL000040 | 5.56 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 432 | Medication, proton pump inhibitor | GASTR000017 | 5.55 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 433 | White matter volume | NIMAG000028 | 5.54 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 434 | DECR1/METAP1D ratio | PRORT000883 | 5.51 | Protein ratios | Muscle / cardiac | 0 | 1 | 5 | 13 | |
| 435 | F9 levels | PROLV000750 | 5.50 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 436 | TNFSF10 levels | PROLV002075 | 5.49 | Protein levels | Hepatocyte | 153 | 2 | 7 | 11 | |
| 437 | MAP4K5/TBCC ratio | PRORT001492 | 5.46 | Protein ratios | Myeloid | 1 | 4 | 12 | 30 | |
| 438 | Subarachnoid haemorrhage | VASCU000018 | 5.45 | Vascular | Granulosa cell | 0 | 0 | 5 | 6 | |
| 439 | Brain functional activity | NIMAG000001 | 5.42 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 440 | CRNN levels | PROLV000528 | 5.42 | Protein levels | Cutaneous epithelium | 11 | 1 | 8 | 10 | |
| 441 | Secondary arthropathy | MSKEL000021 | 5.39 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 442 | Pneumonopathy | RESPI000016 | 5.39 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 443 | BCR/CLIP2 ratio | PRORT000222 | 5.39 | Protein ratios | Epithelial | 1 | 1 | 7 | 5 | |
| 444 | Hypothyroidism, congenital iodine deficiency | ENDOC000013 | 5.38 | Endocrine | Muscle / cardiac | 0 | 1 | 5 | 11 | |
| 445 | Skin ulcer | DERMA000044 | 5.36 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 446 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 5.36 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 447 | FAM151A levels | PROLV000760 | 5.35 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 448 | PLXNA4/SPRY2 ratio | PRORT001685 | 5.33 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 449 | CES3 levels | PROLV000407 | 5.31 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 450 | Sputum production | RESPI000033 | 5.29 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 451 | CXCL12/TIMP3 ratio | PRORT000821 | 5.29 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 452 | Smoking dependency | PSYCH000047 | 5.27 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 453 | Lysine | METAB000026 | 5.20 | Metabolites | Hepatocyte | 1 | 2 | 7 | 16 | |
| 454 | Infant mortality rate | MISCL000003 | 5.19 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 455 | Pain, neck | MSKEL000040 | 5.18 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 456 | ADAMTS8/FAP ratio | PRORT000026 | 5.14 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 457 | Open wound | DERMA000043 | 5.14 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 458 | NOTCH1/TIE1 ratio | PRORT001592 | 5.12 | Protein ratios | Neural / glial | 13 | 3 | 9 | 15 | |
| 459 | Pregnancy complication, vomiting | REPRO000035 | 5.10 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 460 | Pancreas volume | HPBIL000029 | 5.09 | Hepatopancreatobiliary | Pancreatic epithelium | 12 | 0 | 4 | 7 | |
| 461 | Heme malignancy, Plasma cell | MALIG000046 | 5.09 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 462 | FURIN levels | PROLV000835 | 5.08 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 463 | Nerve root disorder | NEURO000030 | 5.01 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 464 | Gut microbial abundance, Prevotella | GASTR000031 | 5.00 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 11 | |
| 465 | Lysine metabolites | METAB000009 | 4.99 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 466 | Ganglion cyst | MSKEL000065 | 4.99 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 467 | Brain structural connectivity | NIMAG000007 | 4.97 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 468 | BLMH/SERPINE1 ratio | PRORT000237 | 4.97 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 469 | Refractive errors | OPHTH000034 | 4.96 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 470 | AGRN levels | PROLV000057 | 4.96 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 471 | Sexually transmitted infection | IMMUN000072 | 4.95 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 472 | Alcoholic liver disease | HPBIL000033 | 4.94 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 473 | GAST levels | PROLV000857 | 4.92 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 474 | SNX9/STIP1 ratio | PRORT001801 | 4.92 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 475 | Synovium, tendon and bursa disorder | MSKEL000057 | 4.86 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 476 | Ocular alignment procedures | OPHTH000026 | 4.86 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 477 | Family history, chronic disease | MISCL000009 | 4.83 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 478 | CD40/TIMP3 ratio | PRORT000446 | 4.82 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 479 | SPTLC1 levels | PROLV001941 | 4.81 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 480 | Abnormal heart sounds | CARDI000051 | 4.80 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 481 | Isoleucine | METAB000024 | 4.80 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 482 | PATE4 levels | PROLV001498 | 4.77 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 483 | Whole body impedance | BCOMP000007 | 4.76 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 484 | Restless legs syndrome, RLS | NEURO000012 | 4.75 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 485 | GMPR levels | PROLV000902 | 4.73 | Protein levels | Neural / glial | 10 | 4 | 7 | 18 | |
| 486 | KLB levels | PROLV001148 | 4.72 | Protein levels | Hepatocyte | 138 | 1 | 9 | 23 | |
| 487 | C3 levels | PROLV000232 | 4.71 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 488 | CNTN3 levels | PROLV000477 | 4.68 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 489 | Hospital stay | MISCL000024 | 4.68 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 490 | GCG levels | PROLV000866 | 4.64 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 491 | ECHS1 levels | PROLV000671 | 4.63 | Protein levels | Hepatocyte | 32 | 4 | 12 | 21 | |
| 492 | Eye disorder | OPHTH000008 | 4.63 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 493 | Cancer, Stomach | MALIG000030 | 4.62 | Malignancy | Myeloid | 2 | 0 | 1 | 9 | |
| 494 | RBP7 levels | PROLV001713 | 4.59 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 495 | YBX1 levels | PROLV002204 | 4.51 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 25 | |
| 496 | Body water mass | BCOMP000006 | 4.49 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 497 | RILPL2 levels | PROLV001735 | 4.44 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 498 | Cortical surface area | NIMAG000009 | 4.43 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 499 | CDH5 levels | PROLV000376 | 4.43 | Protein levels | Vascular | 33 | 3 | 9 | 25 | |
| 500 | AXIN1/CLIP2 ratio | PRORT000167 | 4.41 | Protein ratios | Granulosa cell | 10 | 1 | 5 | 8 | |
| 501 | Polyamine metabolites | METAB000059 | 4.41 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 502 | Leucine | METAB000025 | 4.38 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 503 | CNTN3/FETUB ratio | PRORT000686 | 4.35 | Protein ratios | Hepatocyte | 37 | 1 | 7 | 10 | |
| 504 | DAG1 levels | PROLV000592 | 4.34 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 505 | MPHOSPH8/PSRC1 ratio | PRORT001554 | 4.32 | Protein ratios | Myeloid | 0 | 5 | 11 | 16 | |
| 506 | IL22RA2 levels | PROLV001067 | 4.30 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 507 | Intervertebral disc disorder | MSKEL000076 | 4.29 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 508 | Gut microbial abundance, Olsenella C | GASTR000030 | 4.26 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 509 | Frailty, metabolic problems | METBL000011 | 4.24 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 510 | NT5C1A levels | PROLV001439 | 4.24 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 511 | IGFBP1 levels | PROLV001028 | 4.23 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 512 | Fatty acids unsaturation | LIPID000032 | 4.22 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 513 | CFHR4 levels | PROLV000416 | 4.22 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 514 | IL22 levels | PROLV001066 | 4.21 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 515 | Medication, beta blocker | VASCU000034 | 4.21 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 516 | Hypercalcaemia | METBL000005 | 4.21 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 517 | NPC2 levels | PROLV001419 | 4.20 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 518 | Consultant specialty, general medicine | MISCL000016 | 4.18 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 519 | Low hand grip strength | MSKEL000032 | 4.18 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 520 | BACH1/CD2AP ratio | PRORT000191 | 4.17 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 | |
| 521 | ATRN levels | PROLV000163 | 4.15 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 522 | RGS18 levels | PROLV001731 | 4.14 | Protein levels | Myeloid | 1 | 3 | 8 | 14 | |
| 523 | Heart rate variability | CARDI000022 | 4.13 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 524 | PCDH7 levels | PROLV001507 | 4.13 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 525 | NFATC1/TJAP1 ratio | PRORT001587 | 4.11 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 526 | HS1BP3 levels | PROLV000989 | 4.10 | Protein levels | Stromal / connective | 24 | 6 | 12 | 24 | |
| 527 | Bronchitis | RESPI000001 | 4.09 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 528 | DARS1/MAP4K5 ratio | PRORT000859 | 4.08 | Protein ratios | Muscle / cardiac | 6 | 5 | 14 | 19 | |
| 529 | FOLH1 levels | PROLV000821 | 4.04 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 530 | Urbanicity | SOCIO000029 | 4.03 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 531 | F13B levels | PROLV000744 | 4.02 | Protein levels | Myeloid | 36 | 3 | 14 | 18 | |
| 532 | DKK4/REG1A ratio | PRORT000909 | 3.99 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 533 | Cortical volume | NIMAG000022 | 3.95 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 534 | FEN1 levels | PROLV000789 | 3.94 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 535 | MNDA levels | PROLV001329 | 3.93 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 536 | Viral wart | IMMUN000079 | 3.90 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 537 | IFI30 levels | PROLV001014 | 3.89 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 538 | NRP1 levels | PROLV001434 | 3.89 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 539 | COX5B/METAP1D ratio | PRORT000717 | 3.88 | Protein ratios | Hepatocyte | 10 | 3 | 9 | 12 | |
| 540 | Inflammation and poor diet | MISCL000001 | 3.85 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 541 | APOA2 levels | PROLV000118 | 3.83 | Protein levels | Hepatocyte | 134 | 3 | 9 | 20 | |
| 542 | PSRC1 levels | PROLV001662 | 3.81 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 543 | Phenylalanine metabolites | METAB000012 | 3.81 | Metabolites | Salivary epithelium | 4 | 0 | 4 | 6 | |
| 544 | MENT levels | PROLV001296 | 3.80 | Protein levels | Hepatocyte | 57 | 2 | 10 | 14 | |
| 545 | Radiotherapy | MALIG000049 | 3.80 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 546 | Family medical history, none | MISCL000010 | 3.78 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 547 | Temporomandibular joint disorder | MSKEL000022 | 3.78 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 548 | Hypothyroidism, acquired | ENDOC000012 | 3.76 | Endocrine | Hepatocyte | 1 | 4 | 11 | 37 | |
| 549 | Fat-free mass | BCOMP000008 | 3.74 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 550 | CCL20 levels | PROLV000287 | 3.74 | Protein levels | Myeloid | 32 | 1 | 3 | 2 | |
| 551 | SEZ6 levels | PROLV001840 | 3.73 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 552 | PDGFB/VEGFC ratio | PRORT001652 | 3.70 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 553 | Arrhythmia | CARDI000018 | 3.68 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 554 | OXCT1 levels | PROLV001479 | 3.68 | Protein levels | Myeloid | 26 | 3 | 10 | 10 | |
| 555 | TNFRSF19 levels | PROLV002067 | 3.68 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 556 | RLN2 levels | PROLV001736 | 3.65 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 557 | TOP1 levels | PROLV002087 | 3.64 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 558 | PLA2G15 levels | PROLV001566 | 3.64 | Protein levels | Myeloid | 214 | 2 | 9 | 10 | |
| 559 | Personality disorder | PSYCH000035 | 3.63 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 560 | KCTD5 levels | PROLV001131 | 3.63 | Protein levels | Lymphocyte | 3 | 1 | 12 | 19 | |
| 561 | Skin and soft tissue infection | IMMUN000073 | 3.62 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 562 | Ocular alignment disorder | OPHTH000023 | 3.60 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 563 | LEPR/NRCAM ratio | PRORT001447 | 3.54 | Protein ratios | Epithelial | 23 | 1 | 13 | 18 | |
| 564 | Mammary dysplasia | BREAS000001 | 3.54 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 565 | DNM3 levels | PROLV000639 | 3.53 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 566 | ATG4A levels | PROLV000159 | 3.52 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 567 | LDLR levels | PROLV001194 | 3.52 | Protein levels | Myeloid | 136 | 0 | 4 | 9 | |
| 568 | CEBPB levels | PROLV000395 | 3.49 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 569 | Maximal oxygen uptake | CARDI000026 | 3.48 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 570 | Family history, dyslipidaemia | METBL000010 | 3.47 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 571 | F9/FETUB ratio | PRORT001090 | 3.46 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 15 | |
| 572 | ADHD | PSYCH000033 | 3.46 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 573 | Fibroblastic disorder | MSKEL000064 | 3.45 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 574 | DECR1/FXN ratio | PRORT000881 | 3.45 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 575 | Duodenal ulcer | GASTR000047 | 3.45 | Gastrointestinal | Vascular | 27 | 0 | 4 | 4 | |
| 576 | IGSF9 levels | PROLV001040 | 3.42 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 577 | Family history, diabetes | METBL000009 | 3.42 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 578 | GLT25D1 levels | PROLV000899 | 3.41 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 579 | MLN levels | PROLV001319 | 3.41 | Protein levels | Hepatocyte | 83 | 1 | 4 | 9 | |
| 580 | Asparagine | METAB000018 | 3.41 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 581 | ADAM12 levels | PROLV000025 | 3.39 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 582 | HGFAC levels | PROLV000966 | 3.39 | Protein levels | Hepatocyte | 160 | 3 | 10 | 16 | |
| 583 | Subcortical volume | NIMAG000026 | 3.38 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 584 | SSC5D levels | PROLV001948 | 3.38 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 585 | HYOU1/RARRES2 ratio | PRORT001315 | 3.37 | Protein ratios | Hepatocyte | 29 | 3 | 7 | 14 | |
| 586 | CCL19 levels | PROLV000285 | 3.35 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 587 | LAYN/ULBP2 ratio | PRORT001435 | 3.34 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 588 | Nutritional and metabolic symptoms | METBL000016 | 3.33 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 589 | Cardiac pacemaker | CARDI000049 | 3.33 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 590 | PON2 levels | PROLV001601 | 3.31 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 591 | Phosphatidylinositols | LIPID000061 | 3.30 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 592 | Fatty acids ratio | LIPID000031 | 3.28 | Lipids | Hepatocyte | 426 | 2 | 8 | 18 | |
| 593 | ITM2A levels | PROLV001120 | 3.26 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 594 | HEXIM1/NT5C3A ratio | PRORT001278 | 3.24 | Protein ratios | Hepatocyte | 17 | 4 | 10 | 20 | |
| 595 | Medication, antiglaucoma | OPHTH000014 | 3.23 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 596 | PLXNB2/SEMA7A ratio | PRORT001690 | 3.22 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 597 | Excessive sweating | DERMA000029 | 3.20 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 598 | SIL1 levels | PROLV001866 | 3.20 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 599 | Phosphatidylglycerols | LIPID000060 | 3.19 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 600 | FLT1/VEGFA ratio | PRORT001164 | 3.17 | Protein ratios | Muscle / cardiac | 9 | 2 | 6 | 11 | |
| 601 | CCN2/HBEGF ratio | PRORT000365 | 3.14 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 602 | RBP2 levels | PROLV001711 | 3.14 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 603 | PPP1R2/USP8 ratio | PRORT001708 | 3.13 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 604 | FGR levels | PROLV000804 | 3.11 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 605 | Hospital discharge | MISCL000023 | 3.11 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 606 | BLVRB/HAGH ratio | PRORT000241 | 3.11 | Protein ratios | Neural / glial | 22 | 2 | 7 | 8 | |
| 607 | Taurine metabolites | METAB000014 | 3.10 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 608 | PDGF-BB levels | PROLV001521 | 3.09 | Protein levels | Stromal / connective | 0 | 2 | 2 | 5 | |
| 609 | ALPI levels | PROLV000082 | 3.06 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 610 | DOK2/PPP1R12A ratio | PRORT000941 | 3.06 | Protein ratios | Hepatocyte | 9 | 4 | 11 | 17 | |
| 611 | CEP85/ZBTB16 ratio | PRORT000604 | 3.06 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 612 | EXTL1 levels | PROLV000738 | 3.05 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 613 | Gut microbial abundance, Microvirga | GASTR000029 | 3.04 | Gastrointestinal | Melanocyte | 0 | 7 | 10 | 14 | |
| 614 | CD164 levels | PROLV000313 | 3.03 | Protein levels | Myeloid | 20 | 2 | 10 | 12 | |
| 615 | FOXO3 levels | PROLV000826 | 3.03 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 616 | Benign neoplasm, Melanocytic | MALIG000004 | 3.03 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 617 | Pregnancy complication, ectopic | REPRO000028 | 3.03 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 618 | Frailty, multimorbidity | METBL000012 | 3.02 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 619 | COL6A3/COLEC12 ratio | PRORT000695 | 2.99 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 620 | Shift work | SOCIO000008 | 2.97 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 621 | ATG4A/TPMT ratio | PRORT000150 | 2.94 | Protein ratios | Neural / glial | 0 | 3 | 7 | 13 | |
| 622 | Ocular refraction | OPHTH000033 | 2.93 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 623 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 2.91 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 624 | GP5 levels | PROLV000916 | 2.91 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 625 | SH3GLB2 levels | PROLV001854 | 2.90 | Protein levels | Lymphocyte | 14 | 3 | 17 | 52 | |
| 626 | Wisdom tooth surgery | DENTA000005 | 2.89 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 627 | Operation, gastrointestinal | GASTR000039 | 2.88 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 628 | SERPINA7 levels | PROLV001821 | 2.87 | Protein levels | Hepatocyte | 6 | 3 | 13 | 17 | |
| 629 | Memory disorder | PSYCH000006 | 2.86 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 630 | Body fat percentage, sex interaction | BCOMP000002 | 2.86 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 631 | FABP4 levels | PROLV000754 | 2.85 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 632 | Corpus callosum volume | NIMAG000021 | 2.83 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 633 | CNPY4/STAT5B ratio | PRORT000681 | 2.81 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 634 | F12 levels | PROLV000743 | 2.77 | Protein levels | Myeloid | 72 | 2 | 6 | 11 | |
| 635 | Brain general volume | NIMAG000015 | 2.77 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 636 | GSTT2B levels | PROLV000943 | 2.76 | Protein levels | Muscle / cardiac | 20 | 2 | 5 | 11 | |
| 637 | Heart failure, congestive | CARDI000004 | 2.76 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 638 | NBN levels | PROLV001376 | 2.76 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 639 | LONP1 levels | PROLV001220 | 2.75 | Protein levels | Myeloid | 20 | 3 | 11 | 20 | |
| 640 | IGLL1 levels | PROLV001036 | 2.72 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 641 | CD40/ITGB5 ratio | PRORT000445 | 2.69 | Protein ratios | Myeloid | 8 | 2 | 9 | 17 | |
| 642 | CD84/GP1BA ratio | PRORT000524 | 2.68 | Protein ratios | Vascular | 17 | 2 | 10 | 19 | |
| 643 | FURIN/PLA2G15 ratio | PRORT001185 | 2.68 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 644 | MASP1 levels | PROLV001276 | 2.68 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 645 | PON1 levels | PROLV001600 | 2.68 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 646 | C-reactive protein | HPBIL000026 | 2.67 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 647 | CHMP6 levels | PROLV000432 | 2.67 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 648 | Benign neoplasm, Endocrine | MALIG000003 | 2.67 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 649 | Benign neoplasm, Ocular | MALIG000005 | 2.65 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 650 | GPKOW levels | PROLV000925 | 2.63 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 651 | PLXNA4/VASH1 ratio | PRORT001689 | 2.62 | Protein ratios | Myeloid | 4 | 6 | 15 | 24 | |
| 652 | CCL22 levels | PROLV000289 | 2.61 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 653 | Vestibular disorder | AUDIO000022 | 2.60 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 654 | Cardiomyopathy | CARDI000040 | 2.59 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 655 | Influenza | IMMUN000065 | 2.59 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 656 | CD1C/CD207 ratio | PRORT000391 | 2.59 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 657 | GRHPR levels | PROLV000932 | 2.57 | Protein levels | Stromal / connective | 2 | 5 | 18 | 40 | |
| 658 | S100A11 levels | PROLV001766 | 2.56 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 659 | PDGFB/TIMP3 ratio | PRORT001648 | 2.55 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 660 | PLAT levels | PROLV001571 | 2.54 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 661 | SHISA5 levels | PROLV001856 | 2.54 | Protein levels | Myeloid | 6 | 1 | 3 | 7 | |
| 662 | GFRA1/SPON2 ratio | PRORT001208 | 2.53 | Protein ratios | Hepatocyte | 3 | 1 | 6 | 11 | |
| 663 | Fatty acids metabolites | METAB000052 | 2.53 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 664 | PDGFB/SPARC ratio | PRORT001645 | 2.53 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 665 | Systemic lupus erythematosus, SLE | IMMUN000020 | 2.53 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 666 | NID1/TIMP3 ratio | PRORT001590 | 2.53 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 667 | Steatohepatitis, nonalcoholic | HPBIL000032 | 2.52 | Hepatopancreatobiliary | Renal epithelium | 0 | 0 | 5 | 7 | |
| 668 | ECG-predicted BMI discrepancy | BMORP000008 | 2.51 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 669 | Cancer, Oesophagus | MALIG000021 | 2.51 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 670 | BID levels | PROLV000195 | 2.50 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 671 | FETUB levels | PROLV000790 | 2.50 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 672 | Medication, anti-diabetic | METBL000024 | 2.50 | Metabolic | Hematopoietic progenitor | 156 | 1 | 3 | 7 | |
| 673 | GBP4 levels | PROLV000862 | 2.49 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 674 | Diabetes, secondary | METBL000032 | 2.49 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 675 | FGD3 levels | PROLV000792 | 2.49 | Protein levels | Platelet | 25 | 4 | 8 | 18 | |
| 676 | PCDH1/TNFRSF11A ratio | PRORT001623 | 2.48 | Protein ratios | Myeloid | 1 | 1 | 4 | 11 | |
| 677 | Grey matter volume | NIMAG000023 | 2.48 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 678 | Spermatocele | REPRO000014 | 2.48 | Reproductive | Epithelial | 8 | 0 | 5 | 12 | |
| 679 | ACHE levels | PROLV000012 | 2.47 | Protein levels | Hepatocyte | 125 | 2 | 8 | 15 | |
| 680 | METAP2/USP8 ratio | PRORT001526 | 2.45 | Protein ratios | Hepatocyte | 0 | 2 | 3 | 11 | |
| 681 | TBCB/TBCC ratio | PRORT001827 | 2.45 | Protein ratios | Myeloid | 1 | 2 | 10 | 23 | |
| 682 | Benign neoplasm, Salivary gland | MALIG000006 | 2.45 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 683 | TGFBI/VASN ratio | PRORT001832 | 2.45 | Protein ratios | Hepatocyte | 27 | 2 | 5 | 4 | |
| 684 | DPP6/SEZ6L2 ratio | PRORT000948 | 2.44 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 685 | CASP8/RILP ratio | PRORT000324 | 2.44 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 686 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 2.44 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 687 | CDKN1A/FXN ratio | PRORT000568 | 2.43 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 688 | CRYBB1 levels | PROLV000532 | 2.43 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 689 | Heart rate response to exercise | CARDI000025 | 2.42 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 690 | Osteopenia | MSKEL000009 | 2.42 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 691 | COL6A3/CST3 ratio | PRORT000696 | 2.41 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 692 | Medication, chronic lung disease | RESPI000006 | 2.41 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 693 | Peripheral nerve disorder | NEURO000031 | 2.39 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 694 | Atrophic skin disorder | DERMA000037 | 2.38 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 695 | IRAG2/TBC1D23 ratio | PRORT001367 | 2.37 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 696 | L3HYPDH levels | PROLV001172 | 2.37 | Protein levels | Myeloid | 37 | 4 | 8 | 12 | |
| 697 | PDGFA/SPARC ratio | PRORT001637 | 2.36 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 698 | PDGFB/ST6GAL1 ratio | PRORT001647 | 2.36 | Protein ratios | Neural / glial | 12 | 6 | 11 | 24 | |
| 699 | CPB1/PRSS2 ratio | PRORT000727 | 2.36 | Protein ratios | Granulosa cell | 22 | 0 | 1 | 6 | |
| 700 | PCDH9 levels | PROLV001508 | 2.35 | Protein levels | Myeloid | 32 | 2 | 9 | 15 | |
| 701 | TNFRSF11B levels | PROLV002061 | 2.35 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 702 | CTSD levels | PROLV000562 | 2.34 | Protein levels | Myeloid | 103 | 3 | 12 | 12 | |
| 703 | GPKOW/PXN ratio | PRORT001239 | 2.33 | Protein ratios | Myeloid | 0 | 1 | 5 | 9 | |
| 704 | MINPP1 levels | PROLV001317 | 2.33 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 705 | Branched-chain amino acids | METAB000019 | 2.33 | Metabolites | Hepatocyte | 32 | 3 | 9 | 16 | |
| 706 | SDC4/SEMA4D ratio | PRORT001766 | 2.33 | Protein ratios | Myeloid | 22 | 2 | 5 | 13 | |
| 707 | ATG4A/NSFL1C ratio | PRORT000149 | 2.33 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 5 | 9 | |
| 708 | Spondylosis | MSKEL000081 | 2.33 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 709 | MITD1/SNX9 ratio | PRORT001537 | 2.32 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 710 | Childhood maltreatment | PSYCH000052 | 2.31 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 711 | Pancreas fat | HPBIL000028 | 2.31 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 712 | White matter microstructure | NIMAG000013 | 2.31 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 713 | Glutamine | METAB000021 | 2.30 | Metabolites | Hepatocyte | 401 | 2 | 9 | 18 | |
| 714 | WAS levels | PROLV002184 | 2.29 | Protein levels | Hepatocyte | 25 | 2 | 6 | 11 | |
| 715 | Pancreatitis | HPBIL000027 | 2.29 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 716 | SNAP25 levels | PROLV001906 | 2.28 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 717 | Phosphatidylcholines | LIPID000058 | 2.28 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 718 | PADI4 levels | PROLV001484 | 2.28 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 719 | RARRES2 levels | PROLV001706 | 2.28 | Protein levels | Myeloid | 81 | 3 | 7 | 10 | |
| 720 | CA1 levels | PROLV000239 | 2.27 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 721 | GP1BA levels | PROLV000913 | 2.27 | Protein levels | Myeloid | 60 | 5 | 12 | 17 | |
| 722 | GP1BB levels | PROLV000914 | 2.27 | Protein levels | Lymphocyte | 14 | 3 | 6 | 18 | |
| 723 | CDHR2 levels | PROLV000379 | 2.26 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 724 | VPS4B levels | PROLV002167 | 2.26 | Protein levels | Stromal / connective | 9 | 4 | 8 | 15 | |
| 725 | Breast disorder | BREAS000002 | 2.25 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 726 | RBM17 levels | PROLV001710 | 2.24 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 727 | MOG/RTBDN ratio | PRORT001552 | 2.22 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 728 | CRLF1 levels | PROLV000527 | 2.22 | Protein levels | Hepatocyte | 48 | 3 | 11 | 17 | |
| 729 | INPP5J levels | PROLV001090 | 2.21 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 730 | COVID-19 | IMMUN000054 | 2.21 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 731 | FST levels | PROLV000829 | 2.20 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 732 | CDKN1A/YES1 ratio | PRORT000576 | 2.19 | Protein ratios | Muscle / cardiac | 8 | 4 | 11 | 28 | |
| 733 | Gestational hypertension | VASCU000045 | 2.19 | Vascular | Lymphocyte | 3 | 1 | 7 | 22 | |
| 734 | CRKL/SERPINB1 ratio | PRORT000767 | 2.18 | Protein ratios | Myeloid | 1 | 5 | 15 | 18 | |
| 735 | FABP2 levels | PROLV000752 | 2.17 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 736 | NUDT2 levels | PROLV001454 | 2.16 | Protein levels | Myeloid | 0 | 2 | 7 | 10 | |
| 737 | Brainstem volume | NIMAG000017 | 2.16 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 738 | DECR1/STX8 ratio | PRORT000884 | 2.15 | Protein ratios | Hepatocyte | 9 | 2 | 8 | 15 | |
| 739 | DTNB levels | PROLV000659 | 2.15 | Protein levels | Muscle / cardiac | 0 | 2 | 6 | 24 | |
| 740 | Metabolon metabolite | METAB000076 | 2.14 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 741 | NCF2 levels | PROLV001380 | 2.13 | Protein levels | Muscle / cardiac | 2 | 2 | 7 | 14 | |
| 742 | PRND levels | PROLV001636 | 2.13 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 743 | BLVRB/CA3 ratio | PRORT000240 | 2.13 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 744 | Kidney cyst | NEPHR000004 | 2.13 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 745 | SLC4A1 levels | PROLV001882 | 2.13 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 746 | DCXR/KYNU ratio | PRORT000877 | 2.13 | Protein ratios | Hepatocyte | 13 | 3 | 10 | 15 | |
| 747 | NT5C3A/PRDX5 ratio | PRORT001602 | 2.13 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 748 | HSPG2 levels | PROLV000999 | 2.13 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 749 | ADAM23 levels | PROLV000028 | 2.12 | Protein levels | Granulosa cell | 35 | 1 | 4 | 4 | |
| 750 | Ornithine metabolites | METAB000011 | 2.12 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 751 | Gut microbial abundance, Chromatiales | GASTR000024 | 2.12 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 752 | Methionine metabolites | METAB000010 | 2.10 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 753 | Pregnancy complication, haemorrhage | REPRO000030 | 2.10 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 754 | Medication, sleep apnoea | RESPI000008 | 2.10 | Respiratory | Cutaneous epithelium | 0 | 1 | 8 | 15 | |
| 755 | Coagulation disorder | HEMAT000017 | 2.09 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 756 | IL13RA1 levels | PROLV001047 | 2.08 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 757 | AAGAB levels | PROLV000003 | 2.07 | Protein levels | Hepatocyte | 3 | 1 | 8 | 17 | |
| 758 | OPLAH levels | PROLV001471 | 2.07 | Protein levels | Lymphocyte | 8 | 0 | 7 | 13 | |
| 759 | Tyrosine metabolites | METAB000016 | 2.06 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 760 | PCBP2 levels | PROLV001503 | 2.06 | Protein levels | Lymphocyte | 33 | 4 | 11 | 19 | |
| 761 | COL6A3/NBL1 ratio | PRORT000698 | 2.06 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 762 | KCNA10 levels | PROLV001130 | 2.06 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 763 | Heart rate, exercise | CARDI000017 | 2.05 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 764 | CDKN1A/NCK2 ratio | PRORT000570 | 2.04 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 765 | Enthesopathy | MSKEL000061 | 2.04 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 766 | MFGE8 levels | PROLV001307 | 2.04 | Protein levels | Myeloid | 168 | 3 | 13 | 26 | |
| 767 | LAYN/TNFRSF4 ratio | PRORT001434 | 2.03 | Protein ratios | Myeloid | 8 | 3 | 7 | 11 | |
| 768 | Ventricular volume | CARDI000015 | 2.03 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 769 | AAMDC levels | PROLV000004 | 2.03 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 770 | GUSB levels | PROLV000946 | 2.02 | Protein levels | Hepatocyte | 109 | 2 | 9 | 12 | |
| 771 | DPP7 levels | PROLV000648 | 2.02 | Protein levels | Muscle / cardiac | 129 | 4 | 14 | 27 | |
| 772 | Cataract | OPHTH000012 | 1.97 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 773 | KYNU/SCLY ratio | PRORT001416 | 1.96 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 774 | Connective tissue disorder | MSKEL000060 | 1.96 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 775 | PDGFA/SERPINE1 ratio | PRORT001635 | 1.96 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 776 | SNRPB2 levels | PROLV001910 | 1.95 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 777 | Aortic elasticity | VASCU000049 | 1.95 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 778 | CXCL3/CXCL5 ratio | PRORT000825 | 1.95 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 779 | CSNK1G2 levels | PROLV000543 | 1.95 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 780 | Bacterial intestinal infection | IMMUN000052 | 1.95 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 781 | DAB2/FKBP1B ratio | PRORT000836 | 1.93 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 782 | Androgen metabolite | METAB000071 | 1.93 | Metabolites | Hepatocyte | 77 | 1 | 6 | 13 | |
| 783 | SLA2 levels | PROLV001874 | 1.92 | Protein levels | Stromal / connective | 21 | 4 | 5 | 9 | |
| 784 | ARTN levels | PROLV000148 | 1.92 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 785 | MCEMP1 levels | PROLV001285 | 1.92 | Protein levels | Myeloid | 46 | 3 | 8 | 17 | |
| 786 | SEPTIN8 levels | PROLV001814 | 1.91 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 787 | AMBP/HYOU1 ratio | PRORT000087 | 1.91 | Protein ratios | Hepatocyte | 91 | 2 | 6 | 9 | |
| 788 | CRADD/MAP4K5 ratio | PRORT000748 | 1.91 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 19 | |
| 789 | FUT8/SPARC ratio | PRORT001190 | 1.91 | Protein ratios | Lymphocyte | 1 | 1 | 10 | 24 | |
| 790 | Pyrimidine metabolites | METAB000063 | 1.90 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 791 | ITGB1BP2/WASF1 ratio | PRORT001391 | 1.90 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 792 | PDGFRB levels | PROLV001526 | 1.90 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 793 | VSIG2 levels | PROLV002170 | 1.89 | Protein levels | Renal epithelium | 16 | 0 | 8 | 3 | |
| 794 | Perivascular space burden | NIMAG000011 | 1.89 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 795 | Phosphatidylethanolamines | LIPID000059 | 1.89 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 796 | Creatinine | NEPHR000018 | 1.88 | Nephrourologic | Hepatocyte | 2,903 | 2 | 6 | 8 | |
| 797 | TNFSF11 levels | PROLV002076 | 1.88 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 798 | ENTPD2 levels | PROLV000712 | 1.87 | Protein levels | Hepatocyte | 48 | 1 | 4 | 10 | |
| 799 | CEP43/MPHOSPH8 ratio | PRORT000599 | 1.87 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 800 | GMFG levels | PROLV000901 | 1.86 | Protein levels | Myeloid | 17 | 4 | 9 | 23 | |
| 801 | Healthspan | AGING000004 | 1.85 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 802 | TIMP3/ZBTB16 ratio | PRORT001838 | 1.85 | Protein ratios | Vascular | 1 | 2 | 7 | 20 | |
| 803 | CNPY4/ERBIN ratio | PRORT000679 | 1.84 | Protein ratios | Hepatocyte | 19 | 4 | 7 | 19 | |
| 804 | Diabetes, type 2 | METBL000034 | 1.84 | Metabolic | Hepatocyte | 723 | 0 | 3 | 5 | |
| 805 | Lysophosphatidylcholines | LIPID000054 | 1.83 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 806 | Nephritic syndrome | NEPHR000009 | 1.83 | Nephrourologic | Lymphocyte | — | 2 | 9 | 21 | |
| 807 | EFEMP1/TGFBR3 ratio | PRORT000988 | 1.82 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 808 | CACNA2D3 levels | PROLV000250 | 1.82 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 809 | Ketone bodies | METAB000056 | 1.82 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 810 | Bile acid levels | HPBIL000016 | 1.81 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 811 | CLEC1B/MPIG6B ratio | PRORT000644 | 1.81 | Protein ratios | Myeloid | 4 | 4 | 12 | 13 | |
| 812 | Ventricular sphericity | CARDI000014 | 1.81 | Cardiac | Muscle / cardiac | 0 | 3 | 8 | 21 | |
| 813 | MITD1/WWP2 ratio | PRORT001538 | 1.80 | Protein ratios | Hepatocyte | 0 | 3 | 16 | 32 | |
| 814 | Biliary atresia | HPBIL000002 | 1.80 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 815 | Medication, anti-gout | METBL000025 | 1.79 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 816 | Brain neuroimaging quality metric | NIMAG000006 | 1.79 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 817 | SLC35G2 levels | PROLV001879 | 1.79 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 818 | Delivery | REPRO000004 | 1.79 | Reproductive | Myeloid | 0 | 2 | 5 | 10 | |
| 819 | Obstetric trauma | REPRO000039 | 1.77 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 820 | CXCL5/EDAR ratio | PRORT000827 | 1.76 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 821 | GABBR2 levels | PROLV000845 | 1.76 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 822 | Pulmonary fibrosis | RESPI000017 | 1.75 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 823 | Erysipelas | IMMUN000062 | 1.75 | Immunologic | Hepatocyte | 19 | 2 | 6 | 19 | |
| 824 | BPIFB2 levels | PROLV000211 | 1.75 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 825 | OXT levels | PROLV001480 | 1.75 | Protein levels | Hepatocyte | 94 | 2 | 7 | 11 | |
| 826 | CLEC1A/TNFRSF1A ratio | PRORT000632 | 1.74 | Protein ratios | Vascular | 6 | 5 | 14 | 19 | |
| 827 | CD209/GP2 ratio | PRORT000397 | 1.74 | Protein ratios | Epithelial | 36 | 0 | 3 | 6 | |
| 828 | GALNT2 levels | PROLV000849 | 1.73 | Protein levels | Hepatocyte | 132 | 4 | 10 | 18 | |
| 829 | Personal medical history | MISCL000011 | 1.73 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 830 | ATXN10/SLC27A4 ratio | PRORT000163 | 1.73 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 831 | MYOC levels | PROLV001363 | 1.73 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 832 | Osteoarthritis, OA | MSKEL000012 | 1.73 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 833 | ASAH1 levels | PROLV000149 | 1.73 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 834 | CDH5/PEAR1 ratio | PRORT000560 | 1.73 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 30 | |
| 835 | CSF1/SEMA3F ratio | PRORT000779 | 1.72 | Protein ratios | Hepatocyte | 29 | 1 | 7 | 13 | |
| 836 | Osteomyelitis | IMMUN000068 | 1.72 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 837 | MST1 levels | PROLV001344 | 1.72 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 838 | Iris and ciliary body disorder | OPHTH000005 | 1.72 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 839 | Peripheral artery disease | VASCU000042 | 1.71 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 840 | PDGFB levels | PROLV001523 | 1.71 | Protein levels | Myeloid | 60 | 3 | 12 | 14 | |
| 841 | SIRT2/STAT5B ratio | PRORT001787 | 1.71 | Protein ratios | Hepatocyte | 8 | 2 | 7 | 17 | |
| 842 | Blood disorder | HEMAT000040 | 1.69 | Hematologic | Myeloid | 1 | 3 | 8 | 12 | |
| 843 | Blood pressure, BP, arterial | VASCU000007 | 1.69 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 844 | Family history, hypertension | VASCU000022 | 1.69 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 845 | CASP1 levels | PROLV000265 | 1.68 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 846 | REG1A/REG4 ratio | PRORT001730 | 1.68 | Protein ratios | Hepatocyte | 35 | 1 | 6 | 14 | |
| 847 | Carbohydrate metabolites | METAB000035 | 1.68 | Metabolites | Hepatocyte | 7 | 2 | 13 | 22 | |
| 848 | TSC22D1 levels | PROLV002113 | 1.68 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 849 | DOK2/PPP1R2 ratio | PRORT000942 | 1.68 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 19 | |
| 850 | Arterial stiffness | VASCU000050 | 1.67 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 851 | LGALS4 levels | PROLV001204 | 1.67 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 852 | GAL levels | PROLV000847 | 1.67 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 853 | EREG/GYS1 ratio | PRORT001054 | 1.67 | Protein ratios | Myeloid | 22 | 3 | 14 | 14 | |
| 854 | Dementia | NEURO000019 | 1.67 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 855 | CCL2 levels | PROLV000286 | 1.67 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 856 | RRM2B levels | PROLV001757 | 1.67 | Protein levels | Myeloid | 1 | 3 | 8 | 10 | |
| 857 | SERPINA11 levels | PROLV001815 | 1.66 | Protein levels | Hepatocyte | 203 | 1 | 7 | 13 | |
| 858 | Brain MRI signal intensity | NIMAG000003 | 1.65 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 859 | RNASE4 levels | PROLV001739 | 1.65 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 860 | Iron deficiency anaemia | HEMAT000011 | 1.65 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 861 | IGFBP3 levels | PROLV001030 | 1.65 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 862 | Gastric ulcer | GASTR000048 | 1.65 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 863 | White blood cell disorder | HEMAT000019 | 1.63 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 864 | Medication, bone metabolism | MSKEL000025 | 1.62 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 865 | CPXM1/VEGFC ratio | PRORT000737 | 1.62 | Protein ratios | Hematopoietic progenitor | 21 | 2 | 3 | 15 | |
| 866 | Cancer, Liver | MALIG000018 | 1.62 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 867 | Gastrointestinal polyps | GASTR000005 | 1.62 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 868 | GP2/SELE ratio | PRORT001231 | 1.61 | Protein ratios | Pancreatic epithelium | 13 | 0 | 4 | 10 | |
| 869 | PSAPL1 levels | PROLV001654 | 1.61 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 870 | BCR/ITGB1BP2 ratio | PRORT000227 | 1.60 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 871 | Acylcarnitines | METAB000038 | 1.60 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 872 | XXYLT1 levels | PROLV002201 | 1.58 | Protein levels | Muscle / cardiac | 1 | 2 | 3 | 8 | |
| 873 | COL6A3 levels | PROLV000492 | 1.58 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 874 | BTN2A1/IL18BP ratio | PRORT000257 | 1.57 | Protein ratios | Myeloid | 15 | 2 | 12 | 8 | |
| 875 | PRCP levels | PROLV001624 | 1.57 | Protein levels | Myeloid | 18 | 3 | 10 | 18 | |
| 876 | NECTIN2/TNFRSF1A ratio | PRORT001581 | 1.57 | Protein ratios | Lymphocyte | 12 | 3 | 8 | 19 | |
| 877 | FOXO1/MAP4K5 ratio | PRORT001173 | 1.57 | Protein ratios | Lymphocyte | 0 | 3 | 12 | 41 | |
| 878 | CKAP2 levels | PROLV000438 | 1.56 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 879 | CDH2/SSC4D ratio | PRORT000553 | 1.56 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 14 | |
| 880 | SNCA levels | PROLV001908 | 1.56 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 881 | CPA1/CPB1 ratio | PRORT000718 | 1.56 | Protein ratios | Pancreatic epithelium | 32 | 0 | 1 | 3 | |
| 882 | GFER/TRIAP1 ratio | PRORT001206 | 1.55 | Protein ratios | Granulosa cell | 1 | 4 | 6 | 22 | |
| 883 | PLAUR levels | PROLV001573 | 1.55 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 884 | SNX9/VASH1 ratio | PRORT001802 | 1.55 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 885 | METAP1D levels | PROLV001303 | 1.55 | Protein levels | Myeloid | 4 | 4 | 7 | 16 | |
| 886 | White matter lesion volume | NIMAG000027 | 1.55 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 887 | Organic acid metabolites | METAB000067 | 1.55 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 888 | CACNB3 levels | PROLV000251 | 1.54 | Protein levels | Vascular | 2 | 1 | 3 | 18 | |
| 889 | PTPRN2 levels | PROLV001679 | 1.54 | Protein levels | Pancreatic epithelium | 1 | 0 | 3 | 3 | |
| 890 | DPT levels | PROLV000649 | 1.54 | Protein levels | Myeloid | 31 | 4 | 11 | 21 | |
| 891 | BCAM/CLEC14A ratio | PRORT000207 | 1.54 | Protein ratios | Vascular | 26 | 1 | 12 | 8 | |
| 892 | Cancer, Ovary | MALIG000024 | 1.54 | Malignancy | Gastrointestinal epithelium | 23 | 0 | 7 | 13 | |
| 893 | Copper | METAB000045 | 1.54 | Metabolites | Muscle / cardiac | 0 | 3 | 6 | 21 | |
| 894 | PPP1R14A levels | PROLV001614 | 1.53 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 895 | EIF4G1/PLA2G4A ratio | PRORT001013 | 1.53 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 896 | IGSF3 levels | PROLV001038 | 1.53 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 897 | KLK6/MOG ratio | PRORT001409 | 1.52 | Protein ratios | Myeloid | 8 | 4 | 12 | 15 | |
| 898 | CD84/SEMA4D ratio | PRORT000527 | 1.52 | Protein ratios | Myeloid | 13 | 2 | 5 | 11 | |
| 899 | RRAS levels | PROLV001755 | 1.51 | Protein levels | Lymphocyte | 9 | 2 | 6 | 14 | |
| 900 | Glucose levels | METBL000037 | 1.51 | Metabolic | Hepatocyte | 1,438 | 1 | 6 | 8 | |
| 901 | Oral health conditions, none | DENTA000009 | 1.50 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 902 | Skin pigmentation | DERMA000026 | 1.50 | Dermatologic | Melanocyte | 78 | 1 | 1 | 3 | |
| 903 | Ceramides | LIPID000065 | 1.50 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 904 | CTRL levels | PROLV000559 | 1.50 | Protein levels | Hepatocyte | 128 | 1 | 3 | 7 | |
| 905 | Diabetes, general | METBL000030 | 1.49 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 906 | PLAU/PLAUR ratio | PRORT001678 | 1.49 | Protein ratios | Muscle / cardiac | 29 | 3 | 12 | 22 | |
| 907 | FN1 levels | PROLV000819 | 1.49 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 908 | ANPEP/NT5E ratio | PRORT000102 | 1.48 | Protein ratios | Vascular | 19 | 0 | 4 | 9 | |
| 909 | CFD levels | PROLV000412 | 1.48 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 910 | EIF4B/MAP4K5 ratio | PRORT001007 | 1.48 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 22 | |
| 911 | GGT1 levels | PROLV000883 | 1.48 | Protein levels | Hepatocyte | 87 | 1 | 5 | 7 | |
| 912 | Medication, antipyretic | MISCL000035 | 1.47 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 913 | GP2/LGALS8 ratio | PRORT001230 | 1.47 | Protein ratios | Epithelial | 14 | 1 | 4 | 11 | |
| 914 | MPIG6B/PLXNA4 ratio | PRORT001558 | 1.47 | Protein ratios | Myeloid | 21 | 2 | 7 | 14 | |
| 915 | Hypertensive chronic kidney disease | NEPHR000002 | 1.47 | Nephrourologic | Hepatocyte | 12 | 1 | 5 | 12 | |
| 916 | AK1/PEBP1 ratio | PRORT000063 | 1.47 | Protein ratios | Myeloid | 0 | 1 | 3 | 9 | |
| 917 | GP1BA/SIAE ratio | PRORT001228 | 1.47 | Protein ratios | Myeloid | 2 | 3 | 14 | 22 | |
| 918 | Branched-chain amino acid metabolites | METAB000004 | 1.46 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 919 | Dihexosylceramides | LIPID000066 | 1.46 | Lipids | Neural / glial | 1 | 1 | 2 | 7 | |
| 920 | NPTXR levels | PROLV001428 | 1.45 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 921 | TBCC/WWP2 ratio | PRORT001828 | 1.45 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 15 | |
| 922 | ESAM/PDGFB ratio | PRORT001064 | 1.45 | Protein ratios | Hepatocyte | 8 | 2 | 9 | 28 | |
| 923 | Barrett's oesophagus | GASTR000046 | 1.44 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 924 | Tendinitis | MSKEL000070 | 1.43 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 925 | KL levels | PROLV001147 | 1.43 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 926 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 1.43 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 927 | MPHOSPH8 levels | PROLV001333 | 1.43 | Protein levels | Myeloid | 8 | 2 | 5 | 12 | |
| 928 | Tryptophan | METAB000030 | 1.43 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 929 | CDC37/SNAP29 ratio | PRORT000541 | 1.42 | Protein ratios | Myeloid | 18 | 4 | 13 | 31 | |
| 930 | Body fat percentage, hormone-adjusted | BCOMP000001 | 1.42 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 931 | Dihydrosphingomyelins | LIPID000067 | 1.42 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 932 | NMT1 levels | PROLV001412 | 1.41 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 933 | RP2 levels | PROLV001752 | 1.41 | Protein levels | Vascular | 29 | 2 | 8 | 11 | |
| 934 | Respiratory infection | IMMUN000070 | 1.41 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 935 | PEAR1 levels | PROLV001532 | 1.41 | Protein levels | Myeloid | 16 | 1 | 8 | 12 | |
| 936 | SSC4D/TNFSF10 ratio | PRORT001816 | 1.41 | Protein ratios | Hepatocyte | 11 | 2 | 7 | 14 | |
| 937 | ARHGEF10 levels | PROLV000140 | 1.40 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 938 | Pneumonia | IMMUN000069 | 1.40 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 939 | SERPINA3 levels | PROLV001817 | 1.40 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 940 | APP/CD40LG ratio | PRORT000122 | 1.40 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 941 | CLPS levels | PROLV000463 | 1.40 | Protein levels | Vascular | 68 | 1 | 3 | 10 | |
| 942 | MMP7 levels | PROLV001326 | 1.40 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 943 | Gynaecomastia | BREAS000003 | 1.40 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 944 | AMY1A or AMY1B or AMY1C levels | PROLV000089 | 1.40 | Protein levels | Pancreatic epithelium | 33 | 0 | 7 | 9 | |
| 945 | CCL8 levels | PROLV000300 | 1.39 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 946 | CLIP2/NT5C3A ratio | PRORT000667 | 1.39 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 947 | CNTN1 levels | PROLV000475 | 1.39 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 948 | Heme malignancy, Myeloid | MALIG000045 | 1.38 | Malignancy | Hepatocyte | 0 | 1 | 6 | 15 | |
| 949 | IL17A levels | PROLV001051 | 1.38 | Protein levels | Myeloid | 1 | 4 | 9 | 10 | |
| 950 | Ventricular function | CARDI000008 | 1.38 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 951 | MAP2 levels | PROLV001265 | 1.37 | Protein levels | Muscle / cardiac | 9 | 2 | 5 | 9 | |
| 952 | CD74/IL18BP ratio | PRORT000503 | 1.37 | Protein ratios | Myeloid | 54 | 2 | 5 | 12 | |
| 953 | SSNA1 levels | PROLV001950 | 1.37 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 954 | ADH4/DCXR ratio | PRORT000039 | 1.36 | Protein ratios | Hepatocyte | 17 | 4 | 11 | 18 | |
| 955 | PROS1 levels | PROLV001640 | 1.36 | Protein levels | Hepatocyte | 37 | 1 | 6 | 9 | |
| 956 | Consultant specialty, cardiology | CARDI000037 | 1.34 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 957 | Medication, anticoagulant | VASCU000030 | 1.34 | Vascular | Muscle / cardiac | 85 | 2 | 7 | 18 | |
| 958 | Addison disease | ENDOC000001 | 1.34 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 959 | Hippocampal volume | NIMAG000024 | 1.33 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 960 | MME/NT5E ratio | PRORT001540 | 1.32 | Protein ratios | Hepatocyte | 24 | 1 | 4 | 9 | |
| 961 | RGMB levels | PROLV001729 | 1.31 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 962 | Gut microbial abundance, Staphylococcus | GASTR000036 | 1.30 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 963 | Blood pressure, BP, systolic | VASCU000011 | 1.30 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 964 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 1.29 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 965 | ENTPD5 levels | PROLV000713 | 1.29 | Protein levels | Myeloid | 111 | 3 | 8 | 15 | |
| 966 | Lysophosphatidylinositols | LIPID000056 | 1.29 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 967 | Phosphatidylserines | LIPID000062 | 1.28 | Lipids | B / plasma cell | 0 | 0 | 5 | 17 | |
| 968 | Weight, birth | BMORP000018 | 1.28 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 969 | DCTN1/SCAMP3 ratio | PRORT000873 | 1.28 | Protein ratios | Neural / glial | 15 | 4 | 12 | 24 | |
| 970 | INPP1/TBCC ratio | PRORT001360 | 1.27 | Protein ratios | Hepatocyte | 8 | 1 | 7 | 10 | |
| 971 | Nucleoside metabolites | METAB000061 | 1.27 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 972 | ABHD14B/SCRN1 ratio | PRORT000006 | 1.26 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 973 | Financial satisfaction | SOCIO000024 | 1.26 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 974 | Thyrotoxicosis | ENDOC000024 | 1.26 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 975 | Upper respiratory inflammation | RESPI000041 | 1.26 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 976 | Urticaria | IMMUN000007 | 1.26 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 977 | GABARAPL1 levels | PROLV000844 | 1.26 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 978 | RNASE6 levels | PROLV001740 | 1.25 | Protein levels | Myeloid | 66 | 2 | 5 | 13 | |
| 979 | Drug hypersensitivity | IMMUN000006 | 1.25 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 980 | DKK3/LTBP2 ratio | PRORT000908 | 1.25 | Protein ratios | Neural / glial | 1 | 1 | 5 | 13 | |
| 981 | GGT1/MME ratio | PRORT001214 | 1.24 | Protein ratios | Hepatocyte | 39 | 1 | 5 | 12 | |
| 982 | FKBP1B levels | PROLV000808 | 1.24 | Protein levels | Lymphocyte | 2 | 3 | 9 | 27 | |
| 983 | SNX18 levels | PROLV001912 | 1.23 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 984 | Tryptophan metabolites | METAB000015 | 1.22 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 985 | Histidine metabolites | METAB000008 | 1.22 | Metabolites | Granulosa cell | 3 | 0 | 3 | 9 | |
| 986 | SPESP1 levels | PROLV001926 | 1.22 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 987 | PTGR1 levels | PROLV001666 | 1.22 | Protein levels | Hepatocyte | 38 | 3 | 11 | 18 | |
| 988 | KIRREL2/PLA2G1B ratio | PRORT001406 | 1.21 | Protein ratios | Hepatocyte | 32 | 1 | 6 | 19 | |
| 989 | Chloride | METAB000044 | 1.21 | Metabolites | Hepatocyte | 527 | 0 | 6 | 11 | |
| 990 | Brain susceptibility | NIMAG000008 | 1.20 | Neuroimaging | Myeloid | 139 | 3 | 7 | 12 | |
| 991 | Heme malignancy, Leukaemia | MALIG000042 | 1.20 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 992 | AKT2 levels | PROLV000075 | 1.20 | Protein levels | Stromal / connective | 6 | 3 | 10 | 21 | |
| 993 | SMOC2 levels | PROLV001900 | 1.19 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 994 | CLTA levels | PROLV000466 | 1.19 | Protein levels | Myeloid | 7 | 6 | 11 | 16 | |
| 995 | Bundle branch block | CARDI000029 | 1.19 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 996 | Alanine | METAB000017 | 1.18 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 997 | NECTIN2/SPON2 ratio | PRORT001579 | 1.18 | Protein ratios | Hepatocyte | 17 | 1 | 5 | 10 | |
| 998 | ANXA3/ANXA4 ratio | PRORT000103 | 1.17 | Protein ratios | Myeloid | 0 | 3 | 10 | 14 | |
| 999 | HDLBP levels | PROLV000960 | 1.17 | Protein levels | Hepatocyte | 0 | 1 | 4 | 9 | |
| 1000 | ASAH2 levels | PROLV000150 | 1.16 | Protein levels | Myeloid | 115 | 3 | 7 | 17 |